Background The SARS-CoV-2 pandemic is a global health problem. Beside the specific
pathogenic effect of SARS-CoV-2, incompletely understood deleterious and aberrant host …

For the initial phase of pandemic of coronavirus disease 2019 (COVID-19), repurposing
drugs that in vitro inhibit severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) …

Since a novel coronavirus pneumonia outbreak in late December 2019, coronavirus disease-
19 (COVID-19) epidemic has gradually spread worldwide, becoming a major public health …

The COVID-19 pandemic represents an unprecedented challenge for the researchers to
offer safe, tolerable, and effective treatment strategies for its causative agent known as …

The viral infection due to the new coronavirus or coronavirus disease 2019 (COVID-19),
which was reported for the first time in December 2019, was named by the World Health …

The new type of coronavirus (COVID-19), SARS-CoV-2 originated from Wuhan, China and
has led to a worldwide pandemic. COVID-19 is a novel emerging infectious disease caused …

After online publication of the article, 1 the editor noticed that Figs. 1 and 4 were produced
with the assistance of Servier Medical Art (https://smart. servier. com) without citation. The …

Abstract Novel Corona-virus Disease 2019 (nCOVID 19) is caused by a novel virulent
corona virus and leads to potentially fatal virulent pneumonia and severe respiratory distress …

Coronavirus disease (COVID-19) emerged from Wuhan, has now become pandemic and
the mortality rate is growing exponentially. Clinical complication and fatality rate is much …

The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that suddenly
emerged at the end of December 2019 and caused coronavirus disease 2019 (COVID-19) …